Loading...
XLON
YTT
Market cap3.00bUSD
Nov 07, Last price  
14.40GBP
Name

Zhejiang Yongtai Technology Co Ltd

Chart & Performance

D1W1MN
XLON:YTT chart
P/E
P/S
0.27
EPS
Div Yield, %
Shrs. gr., 5y
0.97%
Rev. gr., 5y
6.00%
Revenues
4.59b
+11.18%
260,680,541288,541,961393,072,284492,811,079511,034,881725,759,212838,874,861769,622,8071,061,449,3421,542,012,5791,748,536,2672,751,122,3063,295,273,7923,429,842,4323,450,306,5504,468,739,4446,336,219,3454,128,040,8204,589,397,832
Net income
-478m
L-22.82%
43,773,43341,149,06243,283,98657,242,92658,318,89063,709,36064,345,31819,848,26183,342,432144,265,024277,018,947182,236,146441,660,042271,699,33277,693,972280,285,674554,106,172-619,761,432-478,353,981
CFO
-111m
L-66.31%
25,206,37615,126,03962,683,83268,107,4260099,803,86322,253,631166,637,10966,258,15184,232,45919,570,675719,671,411382,071,954345,147,877576,003,356223,682,226-329,126,584-110,869,010

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Yongtai Technology Co.,Ltd. engages in the research and development, manufacture, and sale of fluorinate chemicals in China. It offers fluorinated pharmaceutical compounds applied to drugs in fields, including anti-diabetic, anti-virus, cardiovascular, anti-bacterial quinolones, nervous system, etc.; and intermediates used in insecticides and fungicide. The company also provides liquid crystal material, lithium battery material, and other energy materials, as well as contract manufacturing service to pharmaceutical and chemical industry. Zhejiang Yongtai Technology Co.,Ltd. was founded in 1999 and is headquartered in Linhai, China.
IPO date
Dec 22, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT